The diagnostic benefit of antibodies against ribosomal proteins in systemic lupus erythematosus.
Zhen-Rui ShiYan-Fang HanJing YinYu-Ping ZhangZe-Xin JiangLin ZhengGuo-Zhen TanLiangchun WangPublished in: Advances in rheumatology (London, England) (2020)
Anti-Rib-P antibody is not adequate to predict the existence of antibodies against ribosomal P0, P1 and P2 protein. The examination of antibodies against each ribosomal protein is required to achieve additional diagnostic benefit and to evaluate the association with clinical and serological disorders as well.
Keyphrases